You Train Hard and Your Aerobic Capacity Still Lags. Here's Why.

PPARGC1A codes for PGC-1 alpha, a master regulator that tells your muscles to build new mitochondria in response to exercise. When you do endurance training, this protein essentially flips the switch that says “make more energy factories.” Without it, training stimulus doesn’t translate into mitochondrial expansion.

The Gly482Ser variant, present in roughly 35 to 40% of the population, changes how efficiently this protein responds to exercise. People with the Ser variant have a blunted mitochondrial biogenesis response. Your muscles receive the training signal but don’t build new mitochondria as robustly as they should, meaning your aerobic capacity gains plateau much earlier than someone with the Gly variant.

You notice this as a training plateau. You can do higher volume, but your VO2max doesn’t climb. Your pace per watt of effort feels flat. Recovery improves, but aerobic power itself stalls. Other athletes with the same training plan see steady VO2max gains; you don’t.

SOD2 codes for superoxide dismutase 2, an enzyme that lives inside your mitochondria and neutralizes reactive oxygen species (free radicals) produced during aerobic metabolism. When you run hard, your mitochondria are burning fuel at high rates, which generates oxidative stress. SOD2 is your muscle’s line of defense against that damage.

The Val16Ala variant, carried by roughly 40% of the population, impairs this enzyme’s activity. Your mitochondria generate oxidative stress at the same rate as anyone else, but your antioxidant cleanup is 20 to 40% slower, meaning free radicals accumulate and damage muscle protein and mitochondrial DNA. This accelerates fatigue and soreness during training.

You experience this as excessive delayed-onset muscle soreness (DOMS) even after moderate efforts, muscle damage that doesn’t resolve quickly between sessions, and chronic low-grade inflammation that feels like perpetual muscle soreness. Your recovery windows are longer than teammates running the same volume.

MTHFR codes for methylenetetrahydrofolate reductase, an enzyme that converts dietary B vitamins into the active forms your cells need. It’s especially important for red blood cell production and vascular function. When MTHFR works well, your homocysteine stays low and your blood vessels remain flexible. When it doesn’t, homocysteine rises and blood vessels become stiffer.

The C677T variant, present in roughly 40% of people with European ancestry, reduces enzyme efficiency by 30 to 40%. Your blood homocysteine climbs even with adequate B vitamin intake, and your red blood cell turnover becomes less efficient, meaning you carry fewer healthy oxygen-transporting cells per milliliter of blood. Add this to reduced vessel flexibility from high homocysteine, and your oxygen delivery capacity drops noticeably.

You notice this as a persistent ceiling on your aerobic performance even when training feels good. You might feel that you’re working at 85% effort but your pace or power output suggests 75%. Fatigue during long efforts feels disproportionate. Your lactate threshold doesn’t climb despite months of threshold training.

VDR codes for the vitamin D receptor, a protein that sits on muscle cells and receives the signal from activated vitamin D. When this receptor works well, vitamin D tells your muscles to build new protein, recover from training damage, and respond to the training stimulus. Without functional VDR signaling, vitamin D cannot do its job, even if your blood levels look adequate.

VDR variants like BsmI and FokI, present in 30 to 50% of the population depending on ancestry, reduce the sensitivity of this receptor. Your muscles become partially deaf to vitamin D signaling, meaning even adequate or high blood vitamin D levels don’t translate into robust muscle protein synthesis or recovery. Your training stimulus gets blunted at the cellular level.

You experience this as slow recovery between hard sessions, reduced training tolerance (needing longer recovery than teammates running the same volume), and difficulty building aerobic power even when volume is high. Your body composition may lag despite consistent training, and muscle soreness doesn’t resolve as quickly.

ADRB2 codes for the beta-2 adrenergic receptor, a protein on fat cells that listens for the signal “release stored fat.” During endurance exercise, your nervous system releases adrenaline and noradrenaline, which bind to ADRB2 and tell fat cells to break down triglycerides and release fatty acids into the bloodstream. These fatty acids become fuel for your aerobic metabolism.

Variants in ADRB2 like Gln27Glu and Arg16Gly, present in roughly 40% of the population, impair this receptor’s responsiveness. Your fat cells receive the mobilization signal but respond weakly, releasing 20 to 40% less fat into circulation during exercise. This forces your muscles to rely more heavily on carbohydrate, which depletes glycogen faster and limits your aerobic endurance.

You notice this as hitting a wall during longer efforts, despite training your aerobic system extensively. Your body composition may also lag even with consistent training, because your body is less efficient at mobilizing stored fat for fuel. You might rely on carb loading for endurance efforts when others can go longer on fat adaptation.

ACTN3 codes for alpha-actinin-3, a structural protein found in fast-twitch muscle fibers. This protein helps maintain the architecture that makes fast-twitch fibers powerful and explosive. When you have functional ACTN3, your fast-twitch fibers are optimized for power and speed.

The R577X variant creates a null allele, meaning roughly 18% of people with European ancestry have an X/X genotype where neither copy of the gene is functional. People with the X/X genotype lack functional alpha-actinin-3 in their fast-twitch fibers, which doesn’t eliminate fast-twitch fibers but does shift their phenotype toward a more oxidative, endurance-oriented profile.

Interestingly, this isn’t a weakness for aerobic performance. People with the X/X genotype often have a natural endurance advantage and respond well to aerobic training. They experience fewer injuries in endurance sports and tend to have better mitochondrial oxidative capacity relative to power athletes. If you have the X/X genotype and low aerobic capacity, the problem is elsewhere; if you have R/R or R/X and struggle with aerobic work, your genes may naturally predispose you toward power rather than endurance.